BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/13/2026 7:02:56 AM | Browse: 28 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 119490
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Hua-Zhuo-Jie-Du formula alleviates colitis-associated colorectal cancer via regulating phosphatidylinositol 3-kinase/protein kinase B signaling pathway
Manuscript Source Unsolicited Manuscript
All Author List Shao-Pu Hu, Yan-Ru Cai, Yang Liu, Yu-Xi Guo, Xue-Mei Jia, Jian-Ming Jiang and Qian Yang
Funding Agency and Grant Number
Funding Agency Grant Number
Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine No. 2025213
Hebei Natural Science Foundation No. H2024423041
Hebei Natural Science Foundation No. H2023423001
Hebei Natural Science Foundation No. H2024423025
Merit-based Funding Project for Hebei Postdoctoral Researchers’ Scientific Research No. B2024005036
Corresponding Author Qian Yang, MD, PhD, Professor, Department of Gastrointestinal Disease, The First Affiliated Hospital, Hebei University of Chinese Medicine, No. 389 Zhongshan East Road, Changan District, Shijiazhuang 050011, Hebei Province, China. yangqian6909@163.com
Key Words Hua-Zhuo-Jie-Du formula; Colitis-associated colorectal cancer; Network pharmacology; Transcriptomics; Phosphatidylinositol 3-kinase/protein kinase B signaling pathway
Core Tip Hua-Zhuo-Jie-Du formula (HZJDF) has been clinically proven to be effective at preventing colitis-associated colorectal cancer (CAC), but the mechanism for this requires further investigation. This study utilized ultra-high performance liquid chromatography-high-resolution mass spectrometry analysis, network pharmacology, and transcriptomics in an integrated approach to predict the material basis and potential mechanism of action of HZJDF in treating CAC. Furthermore, the prediction results were verified through animal and cell experiments. The results indicated that HZJDF effectively alleviated the tumorigenesis of CAC via inhibiting the phosphatidylinositol 3-kinase/protein kinase B signaling pathway.
Citation Hu SP, Cai YR, Liu Y, Guo YX, Jia XM, Jiang JM, Yang Q. Hua-Zhuo-Jie-Du formula alleviates colitis-associated colorectal cancer via regulating phosphatidylinositol 3-kinase/protein kinase B signaling pathway. World J Gastroenterol 2026; In press
Received
2026-01-29 03:01
Peer-Review Started
2026-01-29 03:01
First Decision by Editorial Office Director
2026-02-06 10:48
Return for Revision
2026-02-06 10:48
Revised
2026-02-12 11:06
Publication Fee Transferred
2026-02-13 00:45
Second Decision by Editor
2026-03-13 02:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-03-13 07:02
Articles in Press
2026-03-13 07:02
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com